BC
Buddhadeb Chakraborty
About Buddhadeb Chakraborty
Data last updated:
Buddhadeb Chakraborty is a Director at Tempest Pharmaceuticals Private Limited (since 2023), Director at Sars Surya Construction Private Limited (since 2023) and Director at Shivam Formulation Private Limited (since 2023), and holds 4 more current directorships. The companies operate in Chemicals, Construction and Trading. The 7 current companies with reported revenue have a combined latest revenue of ₹26.3 Lakh; the largest is Tempest Pharmaceuticals Private Limited at ₹9.7 Lakh (FY 2025). Earlier, Buddhadeb Chakraborty was a Director at Annpurna Investments Consultants Private Limited (2023–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tempest Pharmaceuticals Private Limited U24232WB2007PTC116075 | Director | 10 Jun 2023 | 2007 | ₹9.7 Lakh (FY 2025) | Active |
| Sars Surya Construction Private Limited U45400WB2007PTC116542 | Director | 10 Jun 2023 | 2007 | ₹5.6 Lakh (FY 2025) | Active |
| Shivam Formulation Private Limited U24232WB2007PTC116855 | Director | 10 Jun 2023 | 2007 | ₹4.5 Lakh (FY 2025) | Active |
| Bluetooth Marketing Private Limited U51909WB2010PTC142466 | Director | 10 Jun 2023 | 2010 | ₹1.9 Lakh (FY 2025) | Active |
| Sonata Commosales Private Limited U51909WB2010PTC143213 | Director | 10 Jun 2023 | 2010 | ₹1.8 Lakh (FY 2025) | Active |
| Angler Sales Private Limited U51101WB2010PTC144416 | Director | 10 Jun 2023 | 2010 | ₹1.4 Lakh (FY 2025) | Active |
| Omkarnath Merchants Private Limited U51101WB2010PTC143539 | Director | 10 Jun 2023 | 2010 | ₹1.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Annpurna Investments Consultants Private Limited U51909WB2009PTC138520 | Director | 01 Sep 2023 | 2009 | ₹10.2 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Buddhadeb Chakraborty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishab Jaiswal | 10165215 | Tempest Pharmaceuticals Private Limited , Sars Surya Construction Private Limited and 5 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Buddhadeb Chakraborty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Buddhadeb Chakraborty
Buddhadeb Chakraborty currently holds 7 directorships: Tempest Pharmaceuticals Private Limited (Director, since 10 Jun 2023, revenue ₹9.7 Lakh (FY 2025)); Sars Surya Construction Private Limited (Director, since 10 Jun 2023, revenue ₹5.6 Lakh (FY 2025)); Shivam Formulation Private Limited (Director, since 10 Jun 2023, revenue ₹4.5 Lakh (FY 2025)); Bluetooth Marketing Private Limited (Director, since 10 Jun 2023, revenue ₹1.9 Lakh (FY 2025)); Sonata Commosales Private Limited (Director, since 10 Jun 2023, revenue ₹1.8 Lakh (FY 2025)); and 2 more.
Buddhadeb Chakraborty was first appointed on 10 Jun 2023 as Director at Tempest Pharmaceuticals Private Limited.
The 7 current companies of Buddhadeb Chakraborty that report revenue have a combined latest revenue of ₹26.3 Lakh: Tempest Pharmaceuticals Private Limited ₹9.7 Lakh (FY 2025); Sars Surya Construction Private Limited ₹5.6 Lakh (FY 2025); Shivam Formulation Private Limited ₹4.5 Lakh (FY 2025); Bluetooth Marketing Private Limited ₹1.9 Lakh (FY 2025); Sonata Commosales Private Limited ₹1.8 Lakh (FY 2025); and 2 more.
Buddhadeb Chakraborty held 1 earlier board appointment: Annpurna Investments Consultants Private Limited (Director, 01 Sep 2023 to 30 Apr 2024).
The current boards of Buddhadeb Chakraborty's companies include Rishab Jaiswal (Tempest Pharmaceuticals Private Limited).